QAMZOVA
- Product NDC
- 82972-001
- 11-digit product format
- 829720001
- Labeler code
- 82972
- Product ID
- 82972-001_348c7a0b-c446-d540-e063-6394a90aa4d1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meloxicam
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Nanjing Delova Biotech Co., Ltd.
- Application
- NDA217593
- Marketing category
- NDA
- Marketing start
- 2025-10-15
- Substance
- MELOXICAM
- Active strength
- 30 mg/mL
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- QAMZOVA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MELOXICAM | 30 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VG2QF83CGL |
| Rxcui | 2281106, 2727445 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82972-001-30 | QAMZOVA | 1 in 1 CARTON | INJECTION | 1 | | 2 |
| 82972-001-30 | QAMZOVA | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 82972-001-30 | 82972000130 | 1 VIAL, SINGLE-DOSE in 1 CARTON (82972-001-30) / 1 mL in 1 VIAL, SINGLE-DOSE | 2025-10-15 | No | No | Historical |